{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:38:03Z","timestamp":1789580283610,"version":"build-2803163510"},"reference-count":20,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The reasons for the high risk of contralateral breast cancer are not understood, although polygenic mechanisms have been suggested to be involved. The nationwide Swedish Family-Cancer Database was used to examine the interaction of the risks for contralateral and familial cancer. Relative risks were separately determined for contralateral and familial breast cancers, and these were tested for additive and multiplicative interactions. The Database contained information on 102,176 first breast cancers. Familial risk for breast cancer was 1.76 and the risk for contralateral breast cancer was 3.40, or 5.80 when extrapolated to two breasts. When women had a family history, the risk for contralateral breast cancer was remarkably high, 5.48, or 9.96 when the risk was extrapolated to two breasts, almost identical with 10.21, which was predicted by the multiplicative model. Although the data do not rule out polygenic mechanisms, they suggest that epigenetic imprinting events may be involved for the contralateral breast cancer. [Cancer Res 2007;67(3):868\u201370]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-3854","type":"journal-article","created":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T18:52:50Z","timestamp":1170701570000},"page":"868-870","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Risks for Familial and Contralateral Breast Cancer Interact Multiplicatively and Cause a High Risk"],"prefix":"10.1158","volume":"67","author":[{"given":"Kari","family":"Hemminki","sequence":"first","affiliation":[{"name":"1Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany and"},{"name":"2Center for Family and Community Medicine, Karolinska Institute, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Ji","sequence":"additional","affiliation":[{"name":"2Center for Family and Community Medicine, Karolinska Institute, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Fo\u0308rsti","sequence":"additional","affiliation":[{"name":"1Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany and"},{"name":"2Center for Family and Community Medicine, Karolinska Institute, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,2,5]]},"reference":[{"key":"2022061623230585500_B1","doi-asserted-by":"crossref","unstructured":"Bermejo JL, Hemminki K. Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst\u20082005; 97: 1575\u20139.","DOI":"10.1093\/jnci\/dji338"},{"key":"2022061623230585500_B2","unstructured":"Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev\u20081999; 8: 855\u201361."},{"key":"2022061623230585500_B3","doi-asserted-by":"crossref","unstructured":"Vaittinen P, Hemminki K. Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer\u20082000; 88: 998\u20131002.","DOI":"10.1002\/1097-0215(20001215)88:6<998::AID-IJC25>3.0.CO;2-0"},{"key":"2022061623230585500_B4","doi-asserted-by":"crossref","unstructured":"Hemminki K, Granstrom C. Risk for familial breast cancer increases with age. Nat Genet\u20082002; 32: 233.","DOI":"10.1038\/ng1002-233"},{"key":"2022061623230585500_B5","doi-asserted-by":"crossref","unstructured":"Peto J, Mack TM. High constant incidence in twins and other relatives of women with breast cancer. Nat Genet\u20082000; 26: 411\u20134.","DOI":"10.1038\/82533"},{"key":"2022061623230585500_B6","doi-asserted-by":"crossref","unstructured":"Hartman M, Czene K, Reilly M, et al. Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol\u20082005; 6: 377\u201382.","DOI":"10.1016\/S1470-2045(05)70174-1"},{"key":"2022061623230585500_B7","doi-asserted-by":"crossref","unstructured":"Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos Silva I, Ashworth A, Peto J. Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. Lancet\u20082005; 366: 1554\u20137.","DOI":"10.1016\/S0140-6736(05)67627-1"},{"key":"2022061623230585500_B8","doi-asserted-by":"crossref","unstructured":"Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P. The nation-wide Swedish family-cancer database-updated structure and familial rates. Acta Oncol\u20082001; 40: 772\u20137.","DOI":"10.1080\/02841860152619214"},{"key":"2022061623230585500_B9","unstructured":"Zelterman D. Advanced log-linear models using SAS. Cary (NC): SAS Institute; 2002."},{"key":"2022061623230585500_B10","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. Lyon: IARC Sci Publ; 1987."},{"key":"2022061623230585500_B11","doi-asserted-by":"crossref","unstructured":"Greenland S. Interval estimation by simulation as an alternative to and extension of confidence intervals. Int J Epidemiol\u20082004; 33: 1389\u201397.","DOI":"10.1093\/ije\/dyh276"},{"key":"2022061623230585500_B12","doi-asserted-by":"crossref","unstructured":"Frodin JE, Ericsson J, Barlow L. Multiple primary malignant tumors in a national cancer registry\u2014reliability of reporting. Acta Oncol\u20081997; 36: 465\u20139.","DOI":"10.3109\/02841869709001300"},{"key":"2022061623230585500_B13","doi-asserted-by":"crossref","unstructured":"Stenmark-Askmalm M, Gentile M, Wingren S, Stahl O; South-East Sweden Breast Cancer Group. Protein accumulation and gene mutation of p53 in bilateral breast cancer. Acta Oncol\u20082001; 40: 56\u201362.","DOI":"10.1080\/028418601750071064"},{"key":"2022061623230585500_B14","unstructured":"IARC. Some pharmaceutical drugs. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: IARC; 1996."},{"key":"2022061623230585500_B15","doi-asserted-by":"crossref","unstructured":"Li CI, Malone KE, Weiss NS, Daling JR. Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst\u20082001; 93: 1008\u201313.","DOI":"10.1093\/jnci\/93.13.1008"},{"key":"2022061623230585500_B16","doi-asserted-by":"crossref","unstructured":"Hemminki K, Mutanen P. Genetic epidemiology of multistage carcinogenesis. Mutat Res\u20082001; 473: 11\u201321.","DOI":"10.1016\/S0027-5107(00)00162-7"},{"key":"2022061623230585500_B17","doi-asserted-by":"crossref","unstructured":"Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet\u20082002; 31: 33\u20136.","DOI":"10.1038\/ng853"},{"key":"2022061623230585500_B18","doi-asserted-by":"crossref","unstructured":"Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet\u20082006; 7: 21\u201333.","DOI":"10.1038\/nrg1748"},{"key":"2022061623230585500_B19","doi-asserted-by":"crossref","unstructured":"Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ\u20082006; 174: 341\u20138.","DOI":"10.1503\/cmaj.050774"},{"key":"2022061623230585500_B20","doi-asserted-by":"crossref","unstructured":"Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A\u20082005; 102: 10604\u20139.","DOI":"10.1073\/pnas.0500398102"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/3\/868\/2578428\/868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/3\/868\/2578428\/868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:16:40Z","timestamp":1655435800000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/3\/868\/534015\/Risks-for-Familial-and-Contralateral-Breast-Cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,1]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,2,5]]},"published-print":{"date-parts":[[2007,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-3854","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,1]]}}}